Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2016		Jun. 30, 2015
Cash Flows from Operating Activities:
Net loss	$ (808,162)		$ (794,008)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	27,814		26,303
Stock-based compensation expense	48,000		126,369
Changes in operating assets and liabilities:
Prepaid expenses	28,867		42,077
Inventory	(45,295)		0
Accounts payable and accounts payable – related parties	(62,218)		66,423
Accrued expenses and accrued expenses – related parties	45,527		40,037
Customer deposits	118,500		0
Net Cash Used in Operating Activities	(646,967)		(492,799)
Cash Flows from Investing Activities:
Cost of registering patents	(10,565)		(12,932)
Net Cash Used in Investing Activities	(10,565)		(12,932)
Cash Flows from Financing Activities:
Principal payments on notes payable	(36,772)		(37,274)
Issuance of common stock for cash	0		546,000
Net Cash (Used in) Provided by Financing Activities	(36,772)		508,726
Effect of Foreign Currency Exchange Rates	(1,486)		19,662
Net (decrease) increase in cash	(695,790)		22,657
Cash as of beginning of the period	745,078	[1]	140,496
Cash as of end of the period	49,288		163,153
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	3,568		725
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:
Financing of insurance policies	$ 31,500		$ 37,392

[1] The condensed consolidated balance sheet as of December 31, 2015 has been prepared using information from the audited consolidated balance sheet as of that date.